Familial exudative vitreoretinopathy (FEVR) is a bilateral, clinically and genetically heterogeneous hereditary eye disorder that affects both the retina and the vitreous body. The condition has a high degree of penetrance and variable expressivity. In some cases of autosomal dominant FEVR (AD FEVR), mutations in the frizzled-4 gene (FZD-4) have been shown to be involved in FEVR pathology. In this study, we report that a second unlinked gene (Factor V) is also mutated (Leiden mutation) in the same family, which harbors the FZD-4 gene mutation. These results show for the first time that some families with FEVR could be digenic. While this is unlikely to be a widespread problem, the occurrence of digenic disorders with apparently simple Mendelian inheritance patterns renders the current method of analysis of monogenic disorders by linkage and mutation screening incomplete.
Introduction
Familial exudative vitreoretinopathy (FEVR) is a hereditary eye disorder. It affects both the retina and the vitreous body. The condition is characterized by an abnormal vascularization of the peripheral retina, retinal folds, retinal exudates and tractional retinal detachment ( Figure 1a) . The disorder has a high degree of penetrance and variable expressivity. It is a bilateral disorder and systemic association is absent. 1 Minimally affected individuals do not show any visual symptoms. Although the clinical manifestations of FEVR are similar to retinopathy of prematurity (ROP), FEVR patients do not have a history of oxygen therapy or low birth weight, and have a normal gestational period. In the majority of cases, FEVR is an autosomal dominant (AD) trait, 2 but, recently, a series of X-linked (XL) recessive 3, 4 and a few families with an autosomal recessive (AR) inheritance have been documented. 5, 6 While linkage analysis has not been reported for the AR form, one form of the AD and XL forms has been recently shown to be caused by segregating mutations in the frizzled-4 (FZD-4) and the Norrie disease (ND) gene, respectively. 7 -9 The FZD gene product can function as a receptor for Wnt proteins that have a major role in various cellular processes such as control of cell polarity, malignant transformation and determination of cell fate. Similarly, the ND gene product norrin may function as a dimeric growth factor in the retina. Additionally, the coagulation factor V Leiden mutation is reported to cause peripheral retinal neovascularization. Moreover, the AD and XL forms are genetically heterogeneous disorders.
10,11
Materials and methods Figure 1b ) in this group harbored a mutation in the FZD-4 gene. Since factor V Leiden mutation was reported to cause peripheral retinal neovascularization, we reasoned that it could be involved in some FEVR families that show a variable phenotype. For this purpose, genomic DNA was amplified with a pair of primers, using the procedure described previously. 12 Briefly, the PCR conditions were 30 cycles of 1.5 min at 941C, 1 min at 601C, 1 min at 721C in a buffer containing 5 U of polymerase, 10 pmol each of the primer, 50 mM each of the four doxynucleotides, 1.5 mM MgCl 2 and 10 mM tris-HCl pH 8.3. The amplified product was subjected to restriction analysis. The base change was further identified by a big dye terminator cycle sequencing of the amplified product, according to the procedure supplied by the manufacturer (Applied Biosystems, Foster city, CA, USA). All parents were informed of the purpose of the study and it was approved by the Institutional Review Board of Oakland University, as well as by the Human Subject Investigation Committee of the William Beaumont Hospital.
Results
The coagulation factor V Leiden mutation was reported to cause peripheral retinal neovascularization and central retinal vein thrombosis. 13, 14 It is also weakly associated with advanced ROP, which is a phenocopy of FEVR. 12 Additionally, in a small-scale study, the Leiden mutation is found to be present in 5% of sporadic cases of FEVR. 12 We therefore asked ourselves whether this mutation is also involved in familial FEVR pathology with a variable phenotype. Our extensive analysis has identified a heterozygous Leiden mutation in one familial case of AD FEVR (this same family has a segregating 2 base pair (bp) deletion mutation in the FZD-4 gene 7 ). To detect the factor V Leiden mutation, genomic DNA was amplified with a pair of primers and the amplified product was subjected to restriction digestion using 10 U of MnlI enzyme (the Leiden mutation G-A in exon 10 of the factor V gene destroys one of the MnlI sites in the amplified fragment). The results are shown in Figure 1 . As expected, the normal DNA (unaffected family member) after restriction digestion yields 37, 82 and 104 bp fragments (Figure 1, panel c, lane  2) . However, in the affected patients' DNA (three affected patients' samples are shown) the digestion produced 37, 82, 104 and 141 bp fragments (lanes 4, 6 and 10), suggesting the loss of only one MnlI site (the presence of weaker 37 and 104 bp bands is due to the heterozygosity of the mutation). DNA sequence analysis has further confirmed this base change as well as heterozygosity (panel c, left-hand side). Thus, all affected individuals harbored the same mutation and this mutation is absent in unaffected family members (panel c, lanes 2 and 8), as well as 40 normal controls from four different ethnic backgrounds (one of them matched to the family). The transition mutation, identified in the above study, converted the codon 506 arginine (R) to glutamine (Q) (CGA-CAA), which resulted in the loss of MnlI site. Mutational analysis of the remaining families did not reveal the Leiden mutation in the factor V gene as well as FZD-4 gene, but other mutations may be present in other exons or the promoter region of the gene. However, at present, it is not possible to determine the contributions of each gene to the phenotype because all affected individuals inherited both the mutations in the FZD-4 and factor V gene, and we do not have any additional individuals who have inherited mutations in only one of these genes.
Discussion
Owing to the highly variable pathology of FEVR even within a family, we hypothesized that an unlinked gene may be involved in some cases, similar to digenic retinitis pigmentosa. 15 Strongly supporting evidence was obtained when we screened several families with FEVR pathology using a candidate gene approach. During our routine screening procedure, we have identified one AD FEVR family ( Figure 1, panel b) that has digenic mutations. This same family was reported recently, and contains a segregating 2 bp deletion in the FZD-4 gene. The above two genes that showed mutations in one FEVR family are not linked. The coagulation factor V is mapped to chromosome 1q21 -25 and the FZD-4 gene to chromosome 11q. This cosegregation of unlinked genes in such a small family is statistically very unlikely, but there are precedents in the literature, for instance insulin resistance. 16 Although the FEVR phenotype is highly variable among affected individuals within a family, one of the common features of the disorder in this family is the retinal detachment at an early age, which normally does not occur until the second decade of life. However, FZD-4 gene mutation alone in another family also shows a severe phenotype. 7 Thus, there is no direct correlation between the genotype and the phenotype in the present case. We do not know at present the mechanism by which digenic mutations contribute to the development of variable phenotypes of FEVR. The factor V Leiden mutation seems to enhance the risk of developing neovascular complication. 14 Coagulation factor V undergoes proteolytic inactivation by activated protein C during normal hemostasis. The presence of arginine 506 in factor V was found to be essential for this proteolytic inactivation by activated protein C. Thus, a mutation at this site must be producing a resistant factor V that may lead to abnormal hemostasis. Interestingly, a deficiency of protein S, which is a cofactor for activated protein C, to inactivate factor V, also produces an ROP type (a phenocopy of FEVR) clinical pathology. 13 Additionally, it has been previously reported 7 that mutant FZD-4 is defective in activating components of the Wnt/ Ca 2 þ signaling pathway (calcium/calmodulin-dependent protein kinase II and protein kinase C) due to its altered subcellular localization. Moreover, a mutation in mouse FZD-5 causes defective angiogenesis of the other tissue. 17 Therefore, it is possible that these combined effects may contribute to the abnormal vascularization. However, it is not clear at present whether the Wnt signaling pathway meets with the anticoagulation pathway of factor V and how these combined defects lead to abnormal vascularization of the retina. Whatever the mechanism of the factor V gene mutation, identification of digenic mutations in an unlinked gene in an apparently simple Mendelian disease makes the current approach of linkage and mutational analysis of monogenic disorders incomplete and complicated, although such digenic disorders are rare. 18 
